Cancer chemotherapy lowered risk of Alzheimer’s disease and other neurocognitive disorders that disproportionately affect older people.

Contrary to previous media reports, a new study led by Vanderbilt University Medical Center researchers finds that Medicare Part D prescription drug insurance plans largely favor generic drugs over brand-name counterparts.

After a sharp drop in out-of-pocket costs between 2010 and 2011, Medicare patients who use specialty biologic medications for rheumatoid arthritis have seen higher out-of-pocket spending for those same drugs because of gradual price increases, a new study finds.

When it was determined that a majority of the 19,000 individuals eligible to receive a no-cost annual wellness visit as part of their Medicare coverage had not yet scheduled one, a large task force was assembled at VUMC to contact these patients and schedule their visits

The concept of a single-payer, government-run health care program — Medicare for All — has sparked national debate, and that proposal was the focus of a spirited discussion on Nov. 19 at the Research into Policy and Practice Lecture sponsored by the Department of Health Policy at Vanderbilt University Medical Center.

Cardiac valve surgery patients who participate in a cardiac rehabilitation program have a 34% lower risk of hospitalizations and a 4.2% lower risk of mortality than patients who do not enroll in cardiac rehab in the year after surgery.

Medicare Part D enrollees may pay more out of pocket for high-priced specialty generic drugs than their brand-name counterparts, according to new research by health policy experts at Vanderbilt University Medical Center and the University of North Carolina at Chapel Hill.